Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 1944

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 15
Chunk 1944
---
 and options that are expected to vest subsequent to March 31, 2025 are as follows:

    Schedule of options outstanding that have vested and are expected to
    vest 

    Number of Shares  
    Weighted Average Exercise Price  
    Weighted Average Remaining Contractual Term in Years 
  
    Vested 
     5,795  
    $132.82  
     6.02 
  
    Expected to vest 
     751  
    $112.80  
     6.87 
  
    Total 
     6,546  

The following is a summary of the stock options
outstanding at March 31, 2025 and 2024 and the changes during the years then ended:

    Schedule of stock option activity 

    Fiscal Year Ended March 31, 

    2025  
    2024 

    Options  
    Weighted  Average  Exercise Price  
    Options  
    Weighted Average  Exercise Price 
  
    Outstanding, beginning of year 
     10,816  
    $146.22  
     21,491  
    $180.93 
  
    Granted 
     –  
    $–  
     –  
    $– 
  
    Cancelled/Forfeited 
     (4,270) 
    $170.29  
     (10,675) 
    $215.12 
  
    Outstanding, end of year 
     6,546  
    $130.52  
     10,816  
    $146.22 
  
    Exercisable, end of year 
     5,795  
    $132.82  
     7,236  
    $159.13 
  
    Weighted average estimated fair value of options granted 
        
    $N/A  
        
    $N/A 

     F-20 

Effective as of the close of business on June 6, 2025 with an effective trading date of June 9, 2025, the Company effected
a 1-for-8 reverse stock split of its common stock. All option share figures, including those for prior periods, have been adjusted retrospectively
to reflect the reverse split. Option balances may not tie exactly to prior period filings due to rounding of fractional shares.

There were no stock option grants during the fiscal